Cardiac Differentiation of Pluripotent Stem Cells

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2011 May 24

PMID 21603143

Citations 52

Authors

Kristiina Rajala

Mari Pekkanen-Mattila

Katriina Aalto-Setala

Affiliations

Soon will be listed here.

Abstract

The ability of human pluripotent stem cells to differentiate towards the cardiac lineage has attracted significant interest, initially with a strong focus on regenerative medicine. The ultimate goal to repair the heart by cardiomyocyte replacement has, however, proven challenging. Human cardiac differentiation has been difficult to control, but methods are improving, and the process, to a certain extent, can be manipulated and directed. The stem cell-derived cardiomyocytes described to date exhibit rather immature functional and structural characteristics compared to adult cardiomyocytes. Thus, a future challenge will be to develop strategies to reach a higher degree of cardiomyocyte maturation in vitro, to isolate cardiomyocytes from the heterogeneous pool of differentiating cells, as well as to guide the differentiation into the desired subtype, that is, ventricular, atrial, and pacemaker cells. In this paper, we will discuss the strategies for the generation of cardiomyocytes from pluripotent stem cells and their characteristics, as well as highlight some applications for the cells.

Citing Articles

Control of cell fate upon transcription factor-driven cardiac reprogramming.

Shi H, Spurlock B, Liu J, Qian L Curr Opin Genet Dev. 2024; 89:102226.

PMID: 39586652 PMC: 11894758. DOI: 10.1016/j.gde.2024.102226.

TMEM182 inhibits myocardial differentiation of human iPS cells by maintaining the activated state of Wnt/β-catenin signaling through an increase in ILK expression.

Morihara H, Yokoe S, Wakabayashi S, Takai S FASEB Bioadv. 2024; 6(11):565-579.

PMID: 39512841 PMC: 11539028. DOI: 10.1096/fba.2024-00086.

Signaling Pathways Governing Cardiomyocyte Differentiation.

Mensah I, Gowher H Genes (Basel). 2024; 15(6).

PMID: 38927734 PMC: 11202427. DOI: 10.3390/genes15060798.

Multifocal optical projection microscopy enables label-free 3D measurement of cardiomyocyte cluster contractility.

Belay B, Figueiras E, Hyttinen J, Ahola A Sci Rep. 2023; 13(1):19788.

PMID: 37957157 PMC: 10643565. DOI: 10.1038/s41598-023-46510-4.

Effects of maternal hypothyroidism on postnatal cardiomyocyte proliferation and cardiac disease responses of the progeny.

Li Y, Johnson J, Yang Y, Yu D, Kubo H, Berretta R Am J Physiol Heart Circ Physiol. 2023; 325(4):H702-H719.

PMID: 37539452 PMC: 10659327. DOI: 10.1152/ajpheart.00320.2023.

References

Leschik J, Stefanovic S, Brinon B, Puceat M . Cardiac commitment of primate embryonic stem cells. Nat Protoc. 2008; 3(9):1381-7. DOI: 10.1038/nprot.2008.116. View

Arrell D, Niederlander N, Faustino R, Behfar A, Terzic A . Cardioinductive network guiding stem cell differentiation revealed by proteomic cartography of tumor necrosis factor alpha-primed endodermal secretome. Stem Cells. 2007; 26(2):387-400. DOI: 10.1634/stemcells.2007-0599. View

Reppel M, Pillekamp F, Brockmeier K, Matzkies M, Bekcioglu A, Lipke T . The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J Electrocardiol. 2005; 38(4 Suppl):166-70. DOI: 10.1016/j.jelectrocard.2005.06.029. View

Kim C, Majdi M, Xia P, Wei K, Talantova M, Spiering S . Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev. 2009; 19(6):783-95. PMC: 3135229. DOI: 10.1089/scd.2009.0349. View

Xu C, Police S, Hassanipour M, Gold J . Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells. Stem Cells Dev. 2006; 15(5):631-9. DOI: 10.1089/scd.2006.15.631. View

Zhang H, Bradley A . Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development. 1996; 122(10):2977-86. DOI: 10.1242/dev.122.10.2977. View

Yang L, Soonpaa M, Adler E, Roepke T, Kattman S, Kennedy M . Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453(7194):524-8. DOI: 10.1038/nature06894. View

Otsuji T, Minami I, Kurose Y, Yamauchi K, Tada M, Nakatsuji N . Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs. Stem Cell Res. 2010; 4(3):201-13. DOI: 10.1016/j.scr.2010.01.002. View

Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y . Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009; 460(7251):113-7. DOI: 10.1038/nature08191. View

10.

Peterkin T, Gibson A, Patient R . GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation. EMBO J. 2003; 22(16):4260-73. PMC: 175790. DOI: 10.1093/emboj/cdg400. View

11.

Lindsley R, Gill J, Kyba M, Murphy T, Murphy K . Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development. 2006; 133(19):3787-96. DOI: 10.1242/dev.02551. View

12.

Graichen R, Xu X, Braam S, Balakrishnan T, Norfiza S, Sieh S . Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation. 2007; 76(4):357-70. DOI: 10.1111/j.1432-0436.2007.00236.x. View

13.

Gadue P, Huber T, Paddison P, Keller G . Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci U S A. 2006; 103(45):16806-11. PMC: 1636536. DOI: 10.1073/pnas.0603916103. View

14.

Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M . Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000; 6(2):88-95. PMC: 1949933. View

15.

Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park I . Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation. 2009; 120(15):1513-23. DOI: 10.1161/CIRCULATIONAHA.109.868885. View

16.

Kolossov E, Lu Z, Drobinskaya I, Gassanov N, Duan Y, Sauer H . Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. FASEB J. 2005; 19(6):577-9. DOI: 10.1096/fj.03-1451fje. View

17.

Lindsley R, Gill J, Murphy T, Langer E, Cai M, Mashayekhi M . Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell. 2008; 3(1):55-68. PMC: 2497439. DOI: 10.1016/j.stem.2008.04.004. View

18.

Schneider V, Mercola M . Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 2001; 15(3):304-15. PMC: 312618. DOI: 10.1101/gad.855601. View

19.

He J, Ma Y, Lee Y, Thomson J, Kamp T . Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res. 2003; 93(1):32-9. DOI: 10.1161/01.RES.0000080317.92718.99. View

20.

Foley A, Mercola M . Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev. 2005; 19(3):387-96. PMC: 546516. DOI: 10.1101/gad.1279405. View